Claris Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Sell
7,544
-23
-0.3% -$5.36K 1.01% 17
2025
Q4
$1.57M Buy
7,567
+384
+5% +$75.9K 0.83% 23
2025
Q3
$1.33M Buy
7,183
+910
+15% +$156K 0.76% 27
2025
Q2
$958K Sell
6,273
-1,872
-23% -$288K 0.72% 38
2025
Q1
$1.18M Hold
8,145
0.77% 28
2024
Q4
$1.18M Buy
+8,145
New +$1.26M 0.77% 28

Other funds holding JNJ

Claris Financial's JNJ Position: Q1 2026 in Review

Claris Financial reduced its Johnson & Johnson (JNJ) stake by 0.3% in Q1 2026, selling an estimated $5.36K and leaving 7,544 shares worth $1.84M. The position accounts for 1.01% of the portfolio, ranked #17.

Claris Financial first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Claris Financial held 7,544 shares of Johnson & Johnson worth $1.84M as of Q1 2026.
  • Claris Financial sold 23 Johnson & Johnson shares in Q1 2026, an estimated $5.36K.
  • Johnson & Johnson made up 1.01% of Claris Financial's portfolio in Q1 2026, its #17 holding.
  • Claris Financial first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.